跳至主要内容
临床试验/ISRCTN10137559
ISRCTN10137559已完成未知

Polypharmacy in chronic diseases - reduction of inappropriate medication and adverse drug events in elderly populations by electronic decision support: a multicenter cluster-randomized controlled trial

Witten/Herdecke University (Universität Witten/Herdecke)0 个研究点目标入组 3,904 人开始时间: 2014年7月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
3,904

研究概览

简要总结

  1. 2016 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/26822311 2. 2018 baseline analysis in: http://www.ncbi.nlm.nih.gov/pubmed/30021528 3. 2019 cross-sectional analysis of participant characteristics in: https://www.ncbi.nlm.nih.gov/pubmed/30021528 (added 12/09/2019) 4. 2020 results in: https://pubmed.ncbi.nlm.nih.gov/32554566/ (added 22/06/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age of 75 years and above living in the community or in a nursing home
  • 2. At least 8 continuous drug prescriptions
  • 3. Willing to participate
  • 4. Able to sign informed consent according to the declaration of Helsinki

排除标准

  • 1. Patients with a life expectancy assumed to be less than 1 year, e.g. patients with advanced cancer
  • 2. Patients receiving chemotherapy and/or therapeutic radiation
  • 3. Patients with dementia who are unable to provide informed consent

研究者

发起方
Witten/Herdecke University (Universität Witten/Herdecke)

相似试验

PRIMA-eDS: Polypharmacy in chronic diseases:... | 临床试验